At the moment, achromatopsia is untreatable but red-coloured lenses can be used to reduce sensitivity to bright light. A number of novel interventions are currently under investigation including gene therapy.
The aim of gene therapy for the eye is to restore aspects of vision by using a harmless virus to introduce a normal copy of a defective gene into the cells where it is needed to make it available for use, essentially ‘replacing and correcting’ the defect.